Chimeric Mouse Model with
Highly Humanized Liver
Highly Humanized Liver
KMT Hepatech, Inc. is a part of PhoenixBio group since December 1, 2017
KMT Hepatech is a production facility of PhoenixBio Group products (PXB-mouse® and PXB-cells®) in North America.
PhoenixBio Group is utilizing its proprietary platform technology of small animal model of chimeric mouse with highly humanized liver, the PXB-mouse®.
The PXB-mouse® and PXB-cells® are your essential tools for therapeutics and vaccine development.
Commercial scale production of high quality chimeric mice
Always available for shipment
Stable engraftment for entire lifespan
Long-term applications – over 30 days in study
On-demand supply with consistent donor for in vitro reproducibility
Compatible with your preferred format including 3D
News and Events
1st International NASH Day – June 12
The International NASH Day is the 1st edition of a worldwide movement initiated by the endowment fund The NASH Education ProgramTM aimed at raising awareness about NonAlcoholic SteatoHepatitis (better known…
Meet us at BIO International 2018 in Boston
KMT Hepatech, Inc. – PhoenixBio Group will participate in the Business Forum at BIO International Convention in Boston. Dr. Svetlana Sapelnikova (Vice President, BD Strategy) will take part in the…
Expansion of Staff and Operations in Edmonton
KMT Hepatech, Inc. (“KMT”), a part of PhoenixBio group, announced plans to expand staff and operations by providing services with PXB-Mouse® and starting the production of the PXB-Cells® – hepatocytes isolated from cDNA-uPA/SCID mice with…
KMT Hepatech Announces Strategic Investment from PhoenixBio
KMT Hepatech, Inc. (“KMT”) announced today that it has reached an agreement to join efforts with PhoenixBio Co., Ltd. (PhoenixBio). Together they will advance the use of the cDNA-uPA/SCID mouse model with highly…